Interactive Web-Based Resource for Annotation of Genetic Variants Causing Hereditary Angioedema (HADA): Database Development, Implementation, and Validation
Authors:
- Alejandro Mendoza-AlvarezAlejandro Mendoza-Alvarez
- Adrián Muñoz-BarreraAMAdrián Muñoz-Barrera
- Luis Alberto Rubio-RodríguezLRLuis Alberto Rubio-Rodríguez
- Itahisa Marcelino-RodriguezIMItahisa Marcelino-Rodriguez
- Almudena CorralesACAlmudena Corrales
- Antonio Iñigo-CamposAIAntonio Iñigo-Campos
- Ariel CalleroACAriel Callero
- Eva Perez-RodriguezEPEva Perez-Rodriguez
- Jose Carlos Garcia-RobainaJGJose Carlos Garcia-Robaina
- Rafaela González-MontelongoRGRafaela González-Montelongo
- Jose Miguel Lorenzo-SalazarJLJose Miguel Lorenzo-Salazar
- Carlos FloresCarlos Flores
Open Access
- 9 October 2020
- journal article
- research article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (10) , e19040
Abstract
Background: Hereditary angioedema is a rare genetic condition caused by C1 esterase inhibitor deficiency, dysfunction, or kinin cascade dysregulation, leading to an increased bradykinin plasma concentration. Hereditary angioedema is a poorly recognized clinical entity and is very often misdiagnosed as a histaminergic angioedema. Despite its genetic nature, first-line genetic screening is not integrated in routine diagnosis. Consequently, a delay in the diagnosis, and inaccurate or incomplete diagnosis and treatment of hereditary angioedema are common. Objective: In agreement with recent recommendations from the International Consensus on the Use of Genetics in the Management of Hereditary Angioedema, to facilitate the clinical diagnosis and adapt it to the paradigm of precision medicine and next-generation sequencing–based genetic tests, we aimed to develop a genetic annotation tool, termed Hereditary Angioedema Database Annotation (HADA). Methods: HADA is built on top of a database of known variants affecting function, including precomputed pathogenic assessment of each variant and a ranked classification according to the current guidelines from the American College of Medical Genetics and Genomics. Results: HADA is provided as a freely accessible, user-friendly web-based interface with versatility for the entry of genetic information. The underlying database can also be incorporated into automated command-line stand-alone annotation tools. Conclusions: HADA can achieve the rapid detection of variants affecting function for different hereditary angioedema types, and further integrates useful information to reduce the diagnosis odyssey and improve its delay.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- The mutational constraint spectrum quantified from variation in 141,456 humansNature, 2020
- International Consensus on the Use of Genetics in the Management of Hereditary AngioedemaThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypesHuman Mutation, 2019
- How good are pathogenicity predictors in detecting benign variants?PLOS Computational Biology, 2019
- Clinical implications and considerations for evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelinesGenome Medicine, 2017
- International Cooperation to Enable the Diagnosis of All Rare Genetic DiseasesThe American Journal of Human Genetics, 2017
- Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVarGenetics in Medicine, 2017
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Hereditary AngioedemaArchives of internal medicine (1960), 2001